{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:08:51Z","timestamp":1790755731128,"version":"4.1.0"},"reference-count":58,"publisher":"American Diabetes Association","issue":"4","license":[{"start":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T00:00:00Z","timestamp":1490054400000},"content-version":"vor","delay-in-days":76,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,4,1]]},"abstract":"<jats:p>Type 2 diabetes mellitus (T2DM) is a well-recognized independent risk factor for heart failure. T2DM is associated with altered cardiac energy metabolism, leading to ectopic lipid accumulation and glucose overload, the exact contribution of these two parameters remaining unclear. To provide new insight into the mechanism driving the development of diabetic cardiomyopathy, we studied a unique model of T2DM: lipodystrophic Bscl2\u2212\/\u2212 (seipin knockout [SKO]) mice. Echocardiography and cardiac magnetic resonance imaging revealed hypertrophic cardiomyopathy with left ventricular dysfunction in SKO mice, and these two abnormalities were strongly correlated with hyperglycemia. Surprisingly, neither intramyocardial lipid accumulation nor lipotoxic hallmarks were detected in SKO mice. [18F]Fludeoxyglucose positron emission tomography showed increased myocardial glucose uptake. Consistently, the O-GlcNAcylated protein levels were markedly increased in an SKO heart, suggesting a glucose overload. To test this hypothesis, we treated SKO mice with the hypoglycemic sodium\u2013glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin and the insulin sensitizer pioglitazone. Both treatments reduced the O-GlcNAcylated protein levels in SKO mice, and dapagliflozin successfully prevented the development of hypertrophic cardiomyopathy. Our data demonstrate that glucotoxicity by itself can trigger cardiac dysfunction and that a glucose-lowering agent can correct it. This result will contribute to better understanding of the potential cardiovascular benefits of SGLT2 inhibitors.<\/jats:p>","DOI":"10.2337\/db16-0733","type":"journal-article","created":{"date-parts":[[2017,1,4]],"date-time":"2017-01-04T21:20:31Z","timestamp":1483564831000},"page":"1030-1040","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":143,"title":["The Sodium\u2013Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model"],"prefix":"10.2337","volume":"66","author":[{"given":"Michael","family":"Joubert","sequence":"first","affiliation":[{"name":"L\u2019Institut du Thorax, INSERM, CNRS, Universit\u00e9 de Nantes, Nantes, France"},{"name":"Endocrinologie, CHU Caen, Caen, France"},{"name":"EA 4650, UNICAEN, GIP Cyceron, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Jagu","sequence":"additional","affiliation":[{"name":"L\u2019Institut du Thorax, INSERM, CNRS, Universit\u00e9 de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Montaigne","sequence":"additional","affiliation":[{"name":"Universite Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1011\u2013European Genomic Institute for Diabetes, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Marechal","sequence":"additional","affiliation":[{"name":"Universite Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1011\u2013European Genomic Institute for Diabetes, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Tesse","sequence":"additional","affiliation":[{"name":"L\u2019Institut du Thorax, INSERM, CNRS, Universit\u00e9 de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Ayer","sequence":"additional","affiliation":[{"name":"L\u2019Institut du Thorax, INSERM, CNRS, Universit\u00e9 de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucile","family":"Dollet","sequence":"additional","affiliation":[{"name":"L\u2019Institut du Thorax, INSERM, CNRS, Universit\u00e9 de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Le May","sequence":"additional","affiliation":[{"name":"L\u2019Institut du Thorax, INSERM, CNRS, Universit\u00e9 de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Toumaniantz","sequence":"additional","affiliation":[{"name":"L\u2019Institut du Thorax, INSERM, CNRS, Universit\u00e9 de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Manrique","sequence":"additional","affiliation":[{"name":"EA 4650, UNICAEN, GIP Cyceron, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavien","family":"Charpentier","sequence":"additional","affiliation":[{"name":"L\u2019Institut du Thorax, INSERM, CNRS, Universit\u00e9 de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Staels","sequence":"additional","affiliation":[{"name":"Universite Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1011\u2013European Genomic Institute for Diabetes, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyne","family":"Magr\u00e9","sequence":"additional","affiliation":[{"name":"L\u2019Institut du Thorax, INSERM, CNRS, Universit\u00e9 de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Cariou","sequence":"additional","affiliation":[{"name":"L\u2019Institut du Thorax, INSERM, CNRS, Universit\u00e9 de Nantes, CHU Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Prieur","sequence":"additional","affiliation":[{"name":"L\u2019Institut du Thorax, INSERM, CNRS, Universit\u00e9 de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2017,1,4]]},"reference":[{"key":"2022031210345299500_B1","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1161\/01.CIR.0000012466.50373.E8","article-title":"Adaptation and maladaptation of the heart in diabetes: Part I: general concepts","volume":"105","author":"Taegtmeyer","year":"2002","journal-title":"Circulation"},{"key":"2022031210345299500_B2","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1161\/01.CIR.0000012467.61045.87","article-title":"Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms","volume":"105","author":"Young","year":"2002","journal-title":"Circulation"},{"key":"2022031210345299500_B3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1161\/CIRCHEARTFAILURE.108.794008","article-title":"Discordant short- and long-term outcomes associated with diabetes in patients with heart failure: importance of age and sex: a population study of 5.1 million people in Scotland","volume":"1","author":"MacDonald","year":"2008","journal-title":"Circ Heart Fail"},{"key":"2022031210345299500_B4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am J Cardiol"},{"key":"2022031210345299500_B5","first-page":"1718","article-title":"Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes","volume-title":"Eur Heart J","author":"Seferovi\u0107","year":"2015"},{"key":"2022031210345299500_B6","first-page":"2068","article-title":"Insulin resistance: metabolic mechanisms and consequences in the heart","volume-title":"Arterioscler Thromb Vasc Biol","author":"Abel","year":"2012"},{"key":"2022031210345299500_B7","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.2337\/db11-1805","article-title":"Increased myocardial uptake of dietary fatty acids linked to cardiac dysfunction in glucose-intolerant humans","volume":"61","author":"Labb\u00e9","year":"2012","journal-title":"Diabetes"},{"key":"2022031210345299500_B8","first-page":"109","article-title":"Cardiac lipotoxicity: molecular pathways and therapeutic implications","volume-title":"Curr Heart Fail Rep","author":"Drosatos","year":"2013"},{"key":"2022031210345299500_B9","first-page":"311","article-title":"Lipotoxicity in the heart","volume-title":"Biochim Biophys Acta","author":"Wende","year":"2010"},{"key":"2022031210345299500_B10","first-page":"1272","article-title":"Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart","volume-title":"Circulation","author":"Boudina","year":"2009"},{"key":"2022031210345299500_B11","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.bbalip.2016.02.011","article-title":"Lipotoxicity in obesity and diabetes-related cardiac dysfunction","volume":"1860","author":"Zlobine","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"2022031210345299500_B12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/cvr\/cvr071","article-title":"Glucose metabolism and cardiac hypertrophy","volume":"90","author":"Kolwicz","year":"2011","journal-title":"Cardiovasc Res"},{"key":"2022031210345299500_B13","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.2337\/diabetes.53.9.2366","article-title":"Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob\/ob mouse hearts","volume":"53","author":"Mazumder","year":"2004","journal-title":"Diabetes"},{"key":"2022031210345299500_B14","first-page":"H1693","article-title":"Insulin resistance protects the heart from fuel overload in dysregulated metabolic states","volume-title":"Am J Physiol Heart Circ Physiol","author":"Taegtmeyer","year":"2013"},{"key":"2022031210345299500_B15","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1161\/CIRCULATIONAHA.113.008476","article-title":"Myocardial contractile dysfunction is associated with impaired mitochondrial function and dynamics in type 2 diabetic but not in obese patients","volume":"130","author":"Montaigne","year":"2014","journal-title":"Circulation"},{"key":"2022031210345299500_B16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng585","article-title":"Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13","volume":"28","author":"Magr\u00e9","year":"2001","journal-title":"Nat Genet"},{"key":"2022031210345299500_B17","first-page":"3313","article-title":"Clinical review. Lipodystrophies: genetic and acquired body fat disorders","volume-title":"J Clin Endocrinol Metab","author":"Garg","year":"2011"},{"key":"2022031210345299500_B18","first-page":"245","article-title":"Cardiomyopathy in congenital and acquired generalized lipodystrophy: a clinical assessment","volume-title":"Medicine (Baltimore)","author":"Lupsa","year":"2010"},{"key":"2022031210345299500_B19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0022-3476(86)80389-4","article-title":"Hypertrophic cardiomyopathy in total lipodystrophy","volume":"109","author":"Rheuban","year":"1986","journal-title":"J Pediatr"},{"key":"2022031210345299500_B20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/8904_2011_86","article-title":"A patient with congenital generalized lipodystrophy due to a novel mutation in BSCL2: indications for secondary mitochondrial dysfunction","volume":"4","author":"Jeninga","year":"2012","journal-title":"JIMD Rep"},{"key":"2022031210345299500_B21","first-page":"1019","article-title":"Cardiac steatosis and left ventricular hypertrophy in patients with generalized lipodystrophy as determined by magnetic resonance spectroscopy and imaging","volume-title":"Am J Cardiol","author":"Nelson","year":"2013"},{"key":"2022031210345299500_B22","first-page":"3022","article-title":"Seipin ablation in mice results in severe generalized lipodystrophy","volume-title":"Hum Mol Genet","author":"Cui","year":"2011"},{"key":"2022031210345299500_B23","first-page":"1099","article-title":"Berardinelli-seip congenital lipodystrophy 2\/seipin is a cell-autonomous regulator of lipolysis essential for adipocyte differentiation","volume-title":"Mol Cell Biol","author":"Chen","year":"2012"},{"key":"2022031210345299500_B24","first-page":"1813","article-title":"Thiazolidinediones partially reverse the metabolic disturbances observed in Bscl2\/seipin-deficient mice","volume-title":"Diabetologia","author":"Prieur","year":"2013"},{"key":"2022031210345299500_B25","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1161\/01.CIR.0000160853.19867.61","article-title":"Mouse model of SCN5A-linked hereditary Len\u00e8gre\u2019s disease: age-related conduction slowing and myocardial fibrosis","volume":"111","author":"Royer","year":"2005","journal-title":"Circulation"},{"key":"2022031210345299500_B26","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.diabet.2016.02.002","article-title":"Effects of glycaemic variability on cardiac remodelling after reperfused myocardial infarction: evaluation of streptozotocin-induced diabetic Wistar rats using cardiac magnetic resonance imaging","volume":"42","author":"Joubert","year":"2016","journal-title":"Diabetes Metab"},{"key":"2022031210345299500_B27","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/01.CIR.81.5.1594","article-title":"Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium","volume":"81","author":"Armbrecht","year":"1990","journal-title":"Circulation"},{"key":"2022031210345299500_B28","first-page":"2924","article-title":"Type 1 diabetic akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3","volume-title":"Diabetes","author":"Bugger","year":"2008"},{"key":"2022031210345299500_B29","first-page":"E646","article-title":"Enhanced skeletal muscle lipid oxidative efficiency in insulin-resistant vs insulin-sensitive nondiabetic, nonobese humans","volume-title":"J Clin Endocrinol Metab","author":"Galgani","year":"2013"},{"key":"2022031210345299500_B30","first-page":"300","article-title":"Stabilization of mitochondrial membrane potential prevents doxorubicin-induced cardiotoxicity in isolated rat heart","volume-title":"Toxicol Appl Pharmacol","author":"Montaigne","year":"2010"},{"key":"2022031210345299500_B31","first-page":"187","article-title":"Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization","volume":"30","author":"Brown","year":"1989","journal-title":"J Nucl Med"},{"key":"2022031210345299500_B32","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/0735-1097(88)90476-7","article-title":"Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography","volume":"12","author":"Brown","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"2022031210345299500_B33","first-page":"689","article-title":"Assessment of myocardial metabolism in diabetic rats using small-animal PET: a feasibility study","volume-title":"J Nucl Med","author":"Welch","year":"2006"},{"key":"2022031210345299500_B34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.diabet.2010.09.001","article-title":"O-GlcNAc modification, insulin signaling and diabetic complications","volume":"36","author":"Issad","year":"2010","journal-title":"Diabetes Metab"},{"key":"2022031210345299500_B35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1475-2840-8-39","article-title":"Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography","volume":"8","author":"van den Brom","year":"2009","journal-title":"Cardiovasc Diabetol"},{"key":"2022031210345299500_B36","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1210\/en.2014-1292","article-title":"Molecular mechanisms underlying fasting modulated liver insulin sensitivity and metabolism in male lipodystrophic Bscl2\/Seipin-deficient mice","volume":"155","author":"Chen","year":"2014","journal-title":"Endocrinology"},{"key":"2022031210345299500_B37","first-page":"3022","article-title":"Seipin ablation in mice results in severe generalized lipodystrophy","volume-title":"Hum Mol Genet","author":"Cui","year":"2011"},{"key":"2022031210345299500_B38","first-page":"449","article-title":"Threshold effects of glucose transporter-4 (GLUT4) deficiency on cardiac glucose uptake and development of hypertrophy","volume-title":"J Mol Endocrinol","author":"Kaczmarczyk","year":"2003"},{"key":"2022031210345299500_B39","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/cphy.c150016","article-title":"Glucose transporters in cardiac metabolism and hypertrophy","volume":"6","author":"Shao","year":"2015","journal-title":"Compr Physiol"},{"key":"2022031210345299500_B40","first-page":"33","article-title":"The clinical use of PET with (11)C-acetate","volume-title":"Am J Nucl Med Mol Imaging","author":"Grassi","year":"2012"},{"key":"2022031210345299500_B41","first-page":"454","article-title":"Rodent models of diabetic cardiomyopathy","volume-title":"Dis Model Mech","author":"Bugger","year":"2009"},{"key":"2022031210345299500_B42","first-page":"1320","article-title":"Time course of alterations in myocardial glucose utilization in the Zucker diabetic fatty rat with correlation to gene expression of glucose transporters: a small-animal PET investigation","volume-title":"J Nucl Med","author":"Shoghi","year":"2008"},{"key":"2022031210345299500_B43","first-page":"H2557","article-title":"Role of AMP-activated protein kinase in healthy and diseased hearts","volume-title":"Am J Physiol Heart Circ Physiol","author":"Dolinsky","year":"2006"},{"key":"2022031210345299500_B44","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pharmthera.2013.11.005","article-title":"O-GlcNAc and the cardiovascular system","volume":"142","author":"Dassanayaka","year":"2014","journal-title":"Pharmacol Ther"},{"key":"2022031210345299500_B45","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00726-010-0699-8","article-title":"Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice","volume":"40","author":"Marsh","year":"2011","journal-title":"Amino Acids"},{"key":"2022031210345299500_B46","first-page":"251","article-title":"Proposed regulation of gene expression by glucose in rodent heart","volume-title":"Gene Regul Syst Bio","author":"Young","year":"2007"},{"key":"2022031210345299500_B47","first-page":"R689","article-title":"Excess protein O-GlcNAcylation and the progression of diabetic cardiomyopathy","volume-title":"Am J Physiol Regul Integr Comp Physiol","author":"Fricovsky","year":"2012"},{"key":"2022031210345299500_B48","first-page":"6050","article-title":"Diabetes-associated dysregulation of O-GlcNAcylation in rat cardiac mitochondria","volume-title":"Proc Natl Acad Sci U S A","author":"Banerjee","year":"2015"},{"key":"2022031210345299500_B49","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.biochi.2008.03.005","article-title":"O-GlcNAc modification of FoxO1 increases its transcriptional activity: a role in the glucotoxicity phenomenon?","volume":"90","author":"Kuo","year":"2008","journal-title":"Biochimie"},{"key":"2022031210345299500_B50","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.tem.2008.09.001","article-title":"O-GlcNAc modification of transcription factors, glucose sensing and glucotoxicity","volume":"19","author":"Issad","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"2022031210345299500_B51","first-page":"1109","article-title":"Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice","volume-title":"J Clin Invest","author":"Battiprolu","year":"2012"},{"key":"2022031210345299500_B52","first-page":"442","article-title":"Diuretics prevent thiazolidinedione-induced cardiac hypertrophy without compromising insulin-sensitizing effects in mice","volume-title":"Am J Pathol","author":"Chang","year":"2014"},{"key":"2022031210345299500_B53","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1463-1326.2008.00892.x","article-title":"Pioglitazone and cardiovascular risk. A comprehensive meta-analysis of randomized clinical trials","volume":"10","author":"Mannucci","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"2022031210345299500_B54","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/CIRCULATIONAHA.116.021887","article-title":"Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications","volume":"134","author":"Heerspink","year":"2016","journal-title":"Circulation"},{"key":"2022031210345299500_B55","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2337\/dc16-0330","article-title":"CV protection in the EMPA-REG OUTCOME Trial: a \u201cthrifty substrate\u201d hypothesis","volume":"39","author":"Ferrannini","year":"2016","journal-title":"Diabetes Care"},{"key":"2022031210345299500_B56","first-page":"2232","article-title":"O-GlcNAcylation, enemy or ally during cardiac hypertrophy development?","volume-title":"Biochim Biophys Acta","author":"Mailleux","year":"2016"},{"key":"2022031210345299500_B57","first-page":"2117","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume-title":"N Engl J Med","author":"Zinman","year":"2015"},{"key":"2022031210345299500_B58","first-page":"E1687","article-title":"Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling","volume-title":"Am J Physiol Endocrinol Metab","author":"Hong","year":"2007"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/diabetes.diabetesjournals.org\/syndication\/doi\/10.2337\/db16-0733","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/66\/4\/1030\/537116\/db160733.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/66\/4\/1030\/537116\/db160733.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T11:27:01Z","timestamp":1718969221000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/66\/4\/1030\/16012\/The-Sodium-Glucose-Cotransporter-2-Inhibitor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,4]]},"references-count":58,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,1,4]]},"published-print":{"date-parts":[[2017,4,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db16-0733","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727169800.793565870","asserted-by":"object"}]},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,4]]}}}